Literature DB >> 16200811

Biphasic anaphylactic reactions.

Phil Lieberman1.   

Abstract

OBJECTIVE: To examine the impact of the second phase of a biphasic response on the required observation time after resolution of symptoms that occurred during the initial phase. DATA SOURCES: We performed a MEDLINE search of the literature for studies published between January 1970 and January 2005 on biphasic response using the keywords anaphylaxis, biphasic anaphylaxis, late phase reaction, and early phase reaction. STUDY SELECTION: Prospective studies, retrospective studies, and case reports were selected for inclusion in this review.
RESULTS: The incidence of biphasic anaphylactic reactions as described in the literature is highly variable, ranging from a low of 1% to a high of 20% of episodes. There is no clear consensus regarding distinguishing features of the primary response that predicts the occurrence of a secondary response. However, the severity of the reaction, the time of onset after administration of antigen before the occurrence of symptoms of the primary response, the presence of hypotension or laryngeal edema during the primary response, and the history of a previous biphasic reaction have all been mentioned as risk factors in various studies. The severity of the late-phase reaction is highly variable, and events have ranged from mild to severe with rare fatalities. Most late-phase reactions, however, are mild to moderate in severity. A delay in the administration of epinephrine and too small a dose of epinephrine given for the primary response have also been mentioned as risk factors. It is unclear whether corticosteroids given for the primary event can prevent or ameliorate the second reaction.
CONCLUSIONS: Biphasic responses occur with significant frequency and therefore should be taken into consideration when one considers the observation period after the initial event. An observation period of 8 hours is sufficient for most reactions, but since reactions can occur as long as 72 hours after resolution of the primary event, some authors have recommended a 24-hour waiting period.

Entities:  

Mesh:

Year:  2005        PMID: 16200811     DOI: 10.1016/S1081-1206(10)61217-3

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  46 in total

1.  Pediatric anaphylaxis management in the prehospital setting.

Authors:  Gunjan Kamdar Tiyyagura; Linda Arnold; David C Cone; Melissa Langhan
Journal:  Prehosp Emerg Care       Date:  2013-09-12       Impact factor: 3.077

2.  Biphasic and protracted anaphylaxis to iodinated contrast media.

Authors:  Tae-Hyung Kim; Soon Ho Yoon; Suh-Young Lee; Young Hun Choi; Chang Min Park; Hye-Ryun Kang; Sang-Heon Cho
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

Review 3.  The risk and management of anaphylaxis in the setting of immunotherapy.

Authors:  Phil Lieberman
Journal:  Am J Rhinol Allergy       Date:  2012 Nov-Dec       Impact factor: 2.467

Review 4.  NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population.

Authors:  A Wesley Burks; Stacie M Jones; Joshua A Boyce; Scott H Sicherer; Robert A Wood; Amal Assa'ad; Hugh A Sampson
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

5.  Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C.

Authors:  Akihiko Sakatani; Yoshinori Doi; Takaaki Matsuda; Yasutaka Sasai; Naohiro Nishida; Megumi Sakamoto; Naoto Uenoyama; Yoshiya Matsumoto; Kazuo Kinoshita
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Epinephrine autoinjector prescription filling after pediatric emergency department discharge.

Authors:  Joanna S Cohen; Chisom Agbim; Michael Hrdy; Mary E Mottla; Monika K Goyal; Kristen Breslin
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

Review 7.  Temporal Regulation by Innate Type 2 Cytokines in Food Allergies.

Authors:  Michelle T Graham; Sandra Andorf; Jonathan M Spergel; Talal A Chatila; Kari C Nadeau
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

8.  A new urticarial rash, diarrhoea and refractory hypotension in a man with a history of migraines.

Authors:  Lucy Lamb; David Lowe
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

9.  Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach.

Authors:  Liliane F A De Swert; Dominique Bullens; Marc Raes; Anna-Maria Dermaux
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

10.  Peanut allergy: an overview.

Authors:  Nasser Al-Ahmed; Shirina Alsowaidi; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.